Matthew Keller
Stock Analyst at H.C. Wainwright
(0.21)
# 4,573
Out of 4,994 analysts
98
Total ratings
34.2%
Success rate
-10.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matthew Keller
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ECOR electroCore | Reiterated: Buy | $18 | $12.00 | +50.06% | 1 | Sep 22, 2026 | |
| KYNB Kyntra Bio | Reiterated: Buy | $43 | $7.20 | +497.22% | 15 | Sep 1, 2026 | |
| PHIO Phio Pharmaceuticals | Reiterated: Buy | $14 | $1.01 | +1,286.14% | 10 | Aug 27, 2026 | |
| SXTP 60 Degrees Pharmaceuticals | Reiterated: Hold | n/a | $1.01 | - | 6 | Aug 18, 2026 | |
| ACXP Acurx Pharmaceuticals | Reiterated: Buy | $31 | $1.33 | +2,230.83% | 12 | Aug 14, 2026 | |
| GALT Galectin Therapeutics | Reiterated: Buy | $11 | $3.96 | +177.78% | 11 | Aug 14, 2026 | |
| GYRE Gyre Therapeutics | Reiterated: Buy | $18 | $7.43 | +142.26% | 11 | Aug 7, 2026 | |
| IFRX InflaRx | Reiterated: Buy | $8 | $2.12 | +277.36% | 11 | Aug 6, 2026 | |
| MCRB Seres Therapeutics | Reiterated: Buy | $12 | $4.07 | +194.84% | 3 | Aug 5, 2026 | |
| GRI GRI Bio | Reiterated: Buy | $10 | $1.94 | +415.46% | 9 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.000001 | - | 5 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $33.29 | - | 4 | Oct 30, 2025 |
electroCore
Sep 22, 2026
Reiterated: Buy
Price Target: $18
Current: $12.00
Upside: +50.06%
Kyntra Bio
Sep 1, 2026
Reiterated: Buy
Price Target: $43
Current: $7.20
Upside: +497.22%
Phio Pharmaceuticals
Aug 27, 2026
Reiterated: Buy
Price Target: $14
Current: $1.01
Upside: +1,286.14%
60 Degrees Pharmaceuticals
Aug 18, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.01
Upside: -
Acurx Pharmaceuticals
Aug 14, 2026
Reiterated: Buy
Price Target: $31
Current: $1.33
Upside: +2,230.83%
Galectin Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $11
Current: $3.96
Upside: +177.78%
Gyre Therapeutics
Aug 7, 2026
Reiterated: Buy
Price Target: $18
Current: $7.43
Upside: +142.26%
InflaRx
Aug 6, 2026
Reiterated: Buy
Price Target: $8
Current: $2.12
Upside: +277.36%
Seres Therapeutics
Aug 5, 2026
Reiterated: Buy
Price Target: $12
Current: $4.07
Upside: +194.84%
GRI Bio
May 14, 2026
Reiterated: Buy
Price Target: $10
Current: $1.94
Upside: +415.46%
Mar 30, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.000001
Upside: -
Oct 30, 2025
Downgraded: Hold
Price Target: n/a
Current: $33.29
Upside: -